Humoral immunogenicity of COVID-19 vaccines in patients with inflammatory rheumatic diseases under treatment with Rituximab: a case–control study (COVID-19VacRTX)
出版年份 2022 全文链接
标题
Humoral immunogenicity of COVID-19 vaccines in patients with inflammatory rheumatic diseases under treatment with Rituximab: a case–control study (COVID-19VacRTX)
作者
关键词
-
出版物
RHEUMATOLOGY
Volume -, Issue -, Pages -
出版商
Oxford University Press (OUP)
发表日期
2022-01-25
DOI
10.1093/rheumatology/keac036
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A New SARS CoV-2 Dual Purpose Serology Test: Highly Accurate Infection Tracing and Neutralizing Antibody Response Detection
- (2021) Sean C. Taylor et al. JOURNAL OF CLINICAL MICROBIOLOGY
- SARS-CoV-2 vaccination responses in untreated, conventionally treated and anticytokine-treated patients with immune-mediated inflammatory diseases
- (2021) David Simon et al. ANNALS OF THE RHEUMATIC DISEASES
- Rituximab, but not other antirheumatic therapies, is associated with impaired serological response to SARS- CoV-2 vaccination in patients with rheumatic diseases
- (2021) Robert Spiera et al. ANNALS OF THE RHEUMATIC DISEASES
- Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort
- (2021) Ulf M Geisen et al. ANNALS OF THE RHEUMATIC DISEASES
- Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
- (2021) David S. Khoury et al. NATURE MEDICINE
- Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study
- (2021) Victoria Furer et al. ANNALS OF THE RHEUMATIC DISEASES
- SARS-CoV-2 vaccination in rituximab-treated patients: B cells promote humoral immune responses in the presence of T-cell-mediated immunity
- (2021) Daniel Mrak et al. ANNALS OF THE RHEUMATIC DISEASES
- High antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in patients with rheumatic and musculoskeletal diseases
- (2021) Jake A Ruddy et al. ANNALS OF THE RHEUMATIC DISEASES
- The temporal course of T- and B-cell-responses to vaccination with BNT162b2 and mRNA-1273
- (2021) Robert Markewitz et al. CLINICAL MICROBIOLOGY AND INFECTION
- Updated recommendations of the German Society for Rheumatology for the care of patients with inflammatory rheumatic diseases in the context of the SARS-CoV-2/COVID-19 pandemic, including recommendations for COVID-19 vaccination
- (2021) Christof Specker et al. ZEITSCHRIFT FUR RHEUMATOLOGIE
- COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study
- (2021) Jérôme Avouac et al. Lancet Rheumatology
- Evaluation of the EUROIMMUN Anti-SARS-CoV-2 ELISA Assay for detection of IgA and IgG antibodies
- (2020) Kathleen G. Beavis et al. JOURNAL OF CLINICAL VIROLOGY
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sterilizing immunity to influenza virus infection requires local antigen-specific T cell response in the lungs
- (2016) Avijit Dutta et al. Scientific Reports
- Effect of Methotrexate, Anti-Tumor Necrosis Factor α, and Rituximab on the Immune Response to Influenza and Pneumococcal Vaccines in Patients With Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
- (2013) Charlotte Hua et al. ARTHRITIS CARE & RESEARCH
- Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab
- (2009) Sander van Assen et al. ARTHRITIS AND RHEUMATISM
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now